M.I.TECH (179290) Stock Overview

M.I.TECH Co.,Ltd provides various medical devices in South Korea. The company offers HANAROSTENT, a non-vascular stent; and cosmetic products, including BETTERSKIN, a micro needle patch for wrinkle reduction, whitening, and skin texture improvement, as well as Skin Dr.Ato, a cosmetic in cream, mist, and patch form for allelic inflammation improvement. It also provides blood glucose monitoring systems and strips under the GBIO name; BRT system, device for cleansing skin and injecting the effective component in non-invasive way; ClearView, a device to inject the effective component in non-invasive way, as well as check skin condition before and after treatment; and LIPOEN, a device for custom contouring fat reduction and face lifting. The company was formerly known as Solco Intermed Co., Ltd. and changed its name to M.I.TECH Co.,Ltd in March 1999. The company was founded in 1991 and is headquartered in Pyeongtaek-si, South Korea. As of June 15, 2023, M.I.TECH Co.,Ltd operates as a subsidiary of Boston Scientific Corporation.